News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mason Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| Mason Michael (EVP, CFO & Treasurer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 95,000 shares
@ $0
Sold 11,205 shares
@ $3.0292, valued at
$33.9k
|
|
| 03/01/2023 |
4
| Mason Michael (EVP, CFO & Treasurer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 2,802 shares
@ $3.0368, valued at
$8.5k
|
|
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2022 |
4
| Mason Michael (EVP, CFO & Treasurer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $5.06, valued at
$227.7k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Mason Michael (EVP, CFO & Treasurer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,947 shares
@ $9.862, valued at
$38.9k
|
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Mason Michael (SVP, CFO & Treasurer) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 87,600 options to buy
@ $18, valued at
$1.6M
Granted 32,600 restricted stock units
@ $0 |
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2018 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 1,800 options to buy
@ $88.95, valued at
$160.1k
|
|
| 08/14/2018 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 1,012 shares
@ $0
Paid exercise price by delivering 449 shares
@ $90.95, valued at
$40.8k
Acquired 5 shares
@ $0
Acquired 22 shares
@ $0
Acquired 23 shares
@ $0
Granted 1,666 options to buy
@ $63, valued at
$105k
Granted 2,750 options to buy
@ $96.45, valued at
$265.2k
|
|
| 03/05/2018 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,000 options to buy
@ $119.13, valued at
$476.5k
|
|
| 02/09/2018 |
5
| Mason Michael (VP, Finance and Treasurer) has filed a Form 5 on ALNYLAM PHARMACEUTICALS, INC. |
| 01/08/2018 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 5,249 shares
@ $130.42, valued at
$684.6k
Sold 16,500 shares
@ $131.2, valued at
$2.2M
Sold 12,405 shares
@ $132.18, valued at
$1.6M
Sold 1,591 shares
@ $132.98, valued at
$211.6k
Sold 400 shares
@ $133.83, valued at
$53.5k
Sold 600 shares
@ $135, valued at
$81k
Exercised 1,667 options to buy
@ $63, valued at
$105k
Exercised 2,750 options to buy
@ $96.45, valued at
$265.2k
Exercised 1,388 options to buy
@ $42.22, valued at
$58.6k
Exercised 3,439 options to buy
@ $63, valued at
$216.7k
Exercised 3,600 options to buy
@ $88.95, valued at
$320.2k
|
|
| 01/03/2018 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,538 shares
@ $127.05, valued at
$449.5k
Exercised 8,502 restricted stock units
@ $0 |
|
| 12/21/2017 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 1,388 options to buy
@ $42.22, valued at
$58.6k
|
|
| 11/08/2017 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 1,800 options to buy
@ $88.95, valued at
$160.1k
|
|
| 09/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2016 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 2,750 options to buy
@ $96.45, valued at
$265.2k
|
|
| 12/22/2015 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 7,200 options to buy
@ $88.95, valued at
$640.4k
|
|
| 12/09/2015 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $97.72, valued at
$977.2k
|
|
| 06/03/2015 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 760 shares
@ $130.3921, valued at
$99.1k
Sold 1,767 shares
@ $131.5636, valued at
$232.5k
Sold 2,064 shares
@ $132.4862, valued at
$273.5k
Sold 200 shares
@ $133.12, valued at
$26.6k
Exercised 1,667 options to buy
@ $63, valued at
$105k
Exercised 37 options to buy
@ $63, valued at
$2.3k
Exercised 1,524 options to buy
@ $63, valued at
$96k
Exercised 1,563 options to buy
@ $10.98, valued at
$17.2k
|
|
| 05/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2014 |
4
| Mason Michael (VP, Finance and Treasurer) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 8,704 shares
@ $95.0996, valued at
$827.7k
Sold 4,128 shares
@ $95.9674, valued at
$396.2k
Sold 1,400 shares
@ $97.1179, valued at
$136k
Sold 900 shares
@ $98.4833, valued at
$88.6k
Sold 1,475 shares
@ $99.7349, valued at
$147.1k
Sold 1,835 shares
@ $100.5161, valued at
$184.4k
Sold 2,000 shares
@ $101.747, valued at
$203.5k
Sold 900 shares
@ $102.5622, valued at
$92.3k
Sold 820 shares
@ $103.6001, valued at
$85k
Granted 1,667 options to buy
@ $63, valued at
$105k
Exercised 3,750 options to buy
@ $7.1, valued at
$26.6k
|
|
|
|
|